Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Price Blame Game

Price Blame Game Supporters of plans to allow the reimportation of drugs to the United States from other countries seized on the Medicare card controversy to exert pressure on lawmakers to legalize the practice. The Food and Drug Administration held several forums this spring to debate the safety of reimported drugs, while Congressional hearings focused on whether the United States unfairly shoulders the worldwide costs of drug research and development. At a joint hearing of the Health Care and Foreign Trade Subcommittees, Sen John Kyl (R, Ariz) blamed foreign price controls for high US drug prices, arguing that high prices here subsidize lower prices overseas. He said that allowing US residents to reimport foreign drugs amounted to an importation of unfair price controls. Other senators, including Max Baucus (D, Mont), argued that legalizing reimportation would be an important stopgap while international trade talks proceeded. The House of Representatives has passed legislation allowing drug reimportation; the Senate is considering several similar bills. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Price Blame Game

JAMA , Volume 291 (22) – Jun 9, 2004

Price Blame Game

Abstract

Supporters of plans to allow the reimportation of drugs to the United States from other countries seized on the Medicare card controversy to exert pressure on lawmakers to legalize the practice. The Food and Drug Administration held several forums this spring to debate the safety of reimported drugs, while Congressional hearings focused on whether the United States unfairly shoulders the worldwide costs of drug research and development. At a joint hearing of the Health Care and Foreign Trade...
Loading next page...
 
/lp/american-medical-association/price-blame-game-sSidrEvSO2

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 2004 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.291.22.2691-c
Publisher site
See Article on Publisher Site

Abstract

Supporters of plans to allow the reimportation of drugs to the United States from other countries seized on the Medicare card controversy to exert pressure on lawmakers to legalize the practice. The Food and Drug Administration held several forums this spring to debate the safety of reimported drugs, while Congressional hearings focused on whether the United States unfairly shoulders the worldwide costs of drug research and development. At a joint hearing of the Health Care and Foreign Trade Subcommittees, Sen John Kyl (R, Ariz) blamed foreign price controls for high US drug prices, arguing that high prices here subsidize lower prices overseas. He said that allowing US residents to reimport foreign drugs amounted to an importation of unfair price controls. Other senators, including Max Baucus (D, Mont), argued that legalizing reimportation would be an important stopgap while international trade talks proceeded. The House of Representatives has passed legislation allowing drug reimportation; the Senate is considering several similar bills.

Journal

JAMAAmerican Medical Association

Published: Jun 9, 2004

Keywords: congress (u.s. legislature),drug costs,internship and residency,medicare,shoulder region,medical residencies

There are no references for this article.